Nocathiacins (I), New Thiazolyl Peptide Antibiotics from Nocardia sp. Part 2. Isolation, Characterization, and Structure Determination.

ChemInformVolume 34, Issue 35 Natural Products Nocathiacins (I), New Thiazolyl Peptide Antibiotics from Nocardia sp. Part 2. Isolation, Characterization, and Structure Determination. John E. Leet, John E. Leet Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this authorWenying Li, Wenying Li Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this authorHelen A. Ax, Helen A. Ax Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this authorJames A. Matson, James A. Matson Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this authorStella Huang, Stella Huang Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this authorRon Huang, Ron Huang Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this authorJoseph L. Cantone, Joseph L. Cantone Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this authorDieter Drexler, Dieter Drexler Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this authorRichard A. Dalterio, Richard A. Dalterio Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this authorKin S. Lam, Kin S. Lam Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this author John E. Leet, John E. Leet Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this authorWenying Li, Wenying Li Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this authorHelen A. Ax, Helen A. Ax Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this authorJames A. Matson, James A. Matson Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this authorStella Huang, Stella Huang Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this authorRon Huang, Ron Huang Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this authorJoseph L. Cantone, Joseph L. Cantone Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this authorDieter Drexler, Dieter Drexler Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this authorRichard A. Dalterio, Richard A. Dalterio Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this authorKin S. Lam, Kin S. Lam Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT 06492, USASearch for more papers by this author First published: 04 August 2003 https://doi.org/10.1002/chin.200335176Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume34, Issue35September 2, 2003 RelatedInformation